News & Download Center
News
Articles & Publications
-
Dr. Anton Shufutinsky, Harold Michels, Wilton Moran, Adam Estelle, James Michel, Chris Dreska, Dennis Simon. Poster presented at 2011 US Armed Forces Public Health Conference.
Summary:
Explains the potential application of Antimicrobial Copper
surfaces as a method for preventing surface and airborne microbial
contamination in military healthcare facilities, food handling
operations, and other occupational settings.
Clarification:
The efficacy of Antimicrobial Copper against Influenza A has not
been proven by U.S. EPA-sanctioned testing. No claim of
antimicrobial effectiveness is made, either expressed or implied,
with regard to Influenza A. Clinical trial results are
preliminary and under review; claims related to clinical trials
have not been approved or reviewed by U.S. EPA."
Click below PDF link to view poster in
its entirety.
View [PDF 1323 kB]
-
H. T. Michels, J. O. Noyce, and C. W. Keevil, Letters in Applied Microbiology, 49 (2009) 191-195
Summary:
Demonstrates that commercially available silver ion-containing
coatings marketed as antimicrobial do not exhibit any meaningful
reduction of MRSA under typical indoor conditions. Copper alloys
exhibited antimicrobial efficacy under all tested conditions. Download the full
redacted text here.
Clarification:
This article has been redacted to be consistent with the U.S.
EPA-approved antimicrobial product registration for Antimicrobial
Copper alloys. U.S. EPA-approved testing demonstrates that
Antimicrobial Copper alloys, when cleaned regularly, kill 99.9% of
certain bacteria* (*see article) within two hours. Copper alloys
have been shown to reduce microbial contamination, but not to
prevent cross contamination, and are a supplement to, not a
substitute for, good hygienic practices. Users must follow routine
cleaning and disinfection practices.
-
H. Michels, W. Moran and J. Michel, International Journal of Metalcasting, Summer 08, pp 47-56, 2008
Summary:
Discusses the antimicrobial properties of copper alloys and
their potential to reduce the amount of certain bacteria on
frequently touched surfaces. Efficacy data address other materials
and the effects of tarnishing, bacteria concentration and repeated
contamination. EPA testing, results and registration are
highlighted.
Clarification:
The efficacy of Antimicrobial Copper against Influenza A has not
been proven by U.S. EPA-sanctioned testing. No claim of
antimicrobial effectiveness is made, either express or implied,
with regard to Influenza A. Additionally, Antimicrobial Copper
surfaces are not approved for use in direct food-contact
applications. Antimicrobial copper alloy surfaces have been shown
to reduce microbial contamination, but not necessarily prevent
cross contamination.
-
H. T. Michels and D. G. Anderson, pp 185-190, Metal Ions in Biology and Medicine: Vol. 10., Eds Ph. Collery, I. Maymard, T. Theophanides, L. Khassanova, T. Collery. John Libbey Eurotext, Paris © 2008
Summary:
Discusses potential impact of antimicrobial copper alloys on
amount of certain bacteria on frequently touched surfaces in
healthcare settings. Describes the steps required to make public
health claims and summarizes EPA test protocols and results.
Clarification:
The efficacy of Antimicrobial Copper against Influenza A has not
been proven by U.S. EPA-sanctioned testing. No claim of
antimicrobial effectiveness is made, either expressed or implied,
with regard to Influenza A. Additionally, Antimicrobial Copper
surfaces are not approved for use in direct food-contact
applications.
-
The articles above include conclusions about Antimicrobial Copper that do not reflect EPA product registration approvals. The conclusions reached in these articles are the opinions of the researchers and authors.
The below legal disclaimer is applicable to all above published
articles and publications
*U.S. EPA-approved testing demonstrates efficacy of Antimicrobial Copper surfaces against only the following organisms: Staphylococcus aureus, Enterobacter aerogenes, Escherichia coli O157:H7, Pseudomonas aeruginosa, Methicillin-resistant Staphylococcus aureus (MRSA), and Vancomycin-Resistant Enterococcus faecalis (VRE). Any reference to effectiveness against other organisms has not been proven by U.S. EPA-approved testing. No claim of antimicrobial effectiveness is made, either express or implied, with regard to organisms other than those identified above. Further, any references that state or imply effectiveness in controlling disease or the transmission of bacteria that can cause disease in humans have not been approved by the U.S. EPA or FDA. Antimicrobial Copper surfaces cannot make “infectious disease control” claims. Antimicrobial Copper surfaces have been shown to reduce microbial contamination, but they do not necessarily prevent cross contamination.
*Disclaimer:
The press releases above may include conclusions about
Antimicrobial Copper that do not reflect EPA product registration
approvals. The conclusions reached in these articles are the
opinions of the researchers and authors. U.S. EPA-approved testing
demonstrates efficacy of Antimicrobial Copper surfaces against only
the following organisms: Staphylococcus aureus, Enterobacter
aerogenes, Escherichia coli O157:H7, Pseudomonas aeruginosa,
Methicillin-resistant Staphylococcus aureus (MRSA), and
Vancomycin-Resistant Enterococcus faecalis (VRE). Any reference to
effectiveness against other organisms has not been proven by U.S.
EPA-approved testing. No claim of antimicrobial effectiveness
is made, either express or implied, with regard to organisms other
than those identified above. Further, any references that state or
imply effectiveness in controlling disease or the transmission of
bacteria that can cause disease in humans have not been approved by
the U.S. EPA or FDA. Antimicrobial Copper surfaces cannot make
"infectious disease control" claims. Antimicrobial Copper surfaces
have been shown to reduce microbial contamination, but they do not
necessarily prevent cross contamination.